Julie Person
Chief Administrative Officer at THIRD HARMONIC BIO, INC.
Net worth: - $ as of 30/05/2024
Julie Person active positions
Companies | Position | Start | End |
---|---|---|---|
THIRD HARMONIC BIO, INC. | Chief Administrative Officer | 31/05/2022 | - |
Career history of Julie Person
Former positions of Julie Person
Companies | Position | Start | End |
---|---|---|---|
NEUMORA THERAPEUTICS, INC. | Human Resources Officer | 31/12/2020 | 31/05/2022 |
SANGAMO THERAPEUTICS, INC. | Human Resources Officer | 28/02/2019 | 31/03/2020 |
SHIRE | Human Resources Officer | 31/01/2017 | 28/02/2019 |
AUDENTES THERAPEUTICS, INC. | Human Resources Officer | - | - |
Training of Julie Person
St. Mary's College of California | Undergraduate Degree |
Statistics
International
United States | 6 |
Ireland | 2 |
Operational
Human Resources Officer | 4 |
Chief Administrative Officer | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
THIRD HARMONIC BIO, INC. | Health Technology |
NEUMORA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Julie Person
- Experience